Funded Tech Companies
Anaheim Bio
Wondering who provided funding to Anaheim Bio? Novartis Venture Fund, Thuja Capital and Droia Ventures put venture money into this biopharmaceutical company.
Company Overview
Company Name
Anaheim Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Leiden, Undisclosed
NL
Leiden, Undisclosed
NL
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Anaheim Bio is a preclinical-stage biotechnology company developing small-molecule therapies for calcium pyrophosphate deposition disease (CPPD), a form of inflammatory arthritis. Its lead drug candidate, ANA-1, is designed to lower extracellular pyrophosphate levels and target the underlying cause of crystal formation.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/5/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ilan Ganot
Chief Financial Officer
Rick Dekker
Chief Scientific Officer
Matthias Woensel
Company Investors
- Novartis Venture Fund
- Thuja Capital
- Droia Ventures
- Frazier Life Sciences
- RV Invest
- RTW Investments
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs